In conclusion, our current study demonstrated that Andro ameliorated liver fibrosis in part through suppressing the activation of the TLR4/NF-κB and TGF-β1/Smad2 signaling pathways. The gene discussed is NFKB1; the disease is Hepatic fibrosis.